IgM antibody level against proinflammatory bacterial peptidoglycan is inversely correlated with extent of atherosclerotic disease

Atherosclerosis

Volumn 173, Issue 2, 2004, Pages 245-251

  Nijhuis, Manon M Oude ^a,b,c   Van Der Graaf, Yolanda ^a   Melief, Marie José ^c   Schoneveld, Arjan H ^a,b   De Kleijn, Dominique P V ^a,b   Laman, Jon D ^c   Pasterkamp, Gerard ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ABPI; Ankle brachial pressure index; Atherosclerosis; Gram positive bacteria; Ig; Immune system; Immunoglobulin; IMT; Inflammation; Intima media thickness; Peptidoglycan; PGN; Risk factors; Second Manifestations of ARTerial disease; SMART; TLR; Toll like receptor

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; PEPTIDOGLYCAN;

ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SERUM; SEX; THICKNESS; TUNICA MEDIA;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; IMMUNOGLOBULIN M; INTESTINE, SMALL; MALE; MIDDLE AGED; PEPTIDOGLYCAN; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 1842666909     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.12.005     Document Type: Article

References (30)

1. Ross R.R. Atherosclerosis - an inflammatory disease. New Engl. J. Med. 340:1999;115-126.
2. Glass C.K., Witztum J.L. Atherosclerosis: the road ahead. Cell. 104:2001;503-516.
3. Schrijver I.A., Melief M.J., Eulderink F., Hazenberg M.P., Laman J.D. Bacterial peptidoglycan-polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells. J. Infect. Dis. 179:1999;1459-1468.
4. Martinez-Martinez L., Timmerman C.P., Fleer A., Verhoef J. Chemiluminescence of human polymorphonuclear leukocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermis. J. Med. Microbiol. 39:1993;196-203.
5. Dobrina A., Nardon E., Vecile E., Cinco M., Patriarca P. Leptospira icterohemorrhagiae and leptospire peptidoglycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes. Infect. Immun. 63:1995;2995-2999.
6. Rasanen L., Lehto M., Jokinen I., Leinikki P. Polyclonal antibody formation of human lymphocytes to bacterial components. Immunology. 58:1986;577-581.
7. Wang J.E., Jørgenson P.F., Almlöf M., Solberg R., Okkenhaug C., Scholtz T.et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect. Immun. 68:2000;3965-3970.
8. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarsky R., Golenbock D. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1999;1-5.
9. Kaul D. Molecular link between cholesterol, cytokines and atherosclerosis. Mol. Cell Biochem. 219:2001;65-71.
10. Laman J.D., Schoneveld A.H., Moll F.L., Van Meurs M., Pasterkamp G. Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am. J. Cardiol. 90:2002;119-123.
11. Schrijver I.A., de Man Y., Melief M.J., Van Laar J.M., Markusse H.M., Klasen I.S.et al. Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients. Clin. Exp. Immunol. 123:2001;140-146.
12. Schrijver I.A., Melief M.J., Tak P.P., Hazenberg M.P., Laman J.D. Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthr. Rheum. 43:2000;2160-2168.
13. Simons P.C., Algra A., van de Laak M.F., Grobbee D.E., van der Graaf Y. Second Manifestations of ARTerial disease (SMART) study: rationale and design. Eur. J. Epidemiol. 15:1999;773-781.
14. Hazenberg M.P., Pennock-Schroder A.M., Wensinck F., Van de Merwe J.P. Effect of a soluble bacterial carbohydrate fraction on the viscosity of intestinal contents in healthy subjects and patients with Crohn's disease. Eur. J. Clin. Invest. 19:1989;61-64.
15. Hazenberg M.P., de Visser H., Bras M.J., Prins M.E., Van de Merwe J.P. Serum antibodies to peptidoglycan-polysaccharide complexes from the anaerobic intestinal flora in patients with Crohn's disease. Digestion. 47:1990;172-180.
16. Simons P.C., Algra A., Bots M.L., Banga J.D., Grobbee D.E., van der Graaf Y. for the SMART Study Group Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation. 100:1999;951-957.
17. Brandtzaeg P. The role of humoral mucosal immunity in the induction and maintenance of chronic airway infections. Am. J. Respir. Crit. Care Med. 151:1995;2081-2086.
18. Hulthe J., Wikstrand J., Lidell A., Wendelhag I., Hansson G.K., Wiklund O. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 18:1998;1203-1211.
19. Hulthe J., Bokemark L., Fagerberg B. Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men. Arterioscler. Thromb. Vasc. Biol. 21:2001;101-107.
20. Wu R., de Faire U., Lemne C., Frostegård J. Autoantibodies to Ox-LDL are decreased in individuals with borderline hypertension. Hypertension. 33:1999;53-59.
21. Ameli S., Hultgårdh-Nilsson A., Regnström J., Calara F., Yano J., Cercek B.et al. Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler. Thromb. Vasc. Biol. 16:1996;1074-1079.
22. Maron R., Sukhova G., Faria A.M., Hoffmann E., Mach F., Libby P.et al. Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation. 106:2002;1708-1715.
23. Caligiuri G., Nicoletti A., Poirier B., Hansson G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109:2002;745-753.
24. Shaw P.X., Hörkkö S., Chang M.K., Curtiss L.K., Palinski W., Silverman G.J.et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J. Clin. Invest. 105:2000;1731-1740.
25. Virella G., Lopes-Virella M.F. Humoral immunity and atherosclerosis. Natl. Med. 9:2003;243-244.
26. Schumacher A., Seljeflot I., Lerkerod A.B., Sommervoll L., Otterstad J.E., Arnesen H. Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis. 164:2002;153-160.
27. Schumacher A., Seljeflot I., Lerkerod A.B., Sommervoll L., Otterstad J.E., Arnesen H. Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans? Clin. Microbiol. Infect. 8:2002;654-661.
28. Siscovick D.S., Schwartz S.M., Corey L., Grayston J.T., Ashley R., Wang S.-P.et al. Chlamydia pneumoniae, Herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults. The Cardiovascular Health Study. Circulation. 102:2000;2335-2340.
29. Kowalski M., Rees W., Konturek P.C., Grove R., Scheffold T., Meixner H. et al. Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig. Liver Dis. 34:2002;398-402.
30. De Backer J., Mak R., De Bacquer D., Van Renterghem L., Verbaekel E., Kornitzer M.et al. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 160:2002;457-463.